Search for

Bibliographia Humboldtiana Index

Bibliographia Humboldtiana

III. Publications by Research Awardees in 2014

Medicine

Jeremic, Prof. Dr. Branislav

BioIRC - Bioengineering Research and Development Center, Serbia
Field of research: X-ray therapy, radiotherapy
Host: Prof. Dr. Michael Molls Technische Universität München
  • Hale Caglar, Francesc Casas, Luhua Wang, Branislav Jeremic.: Lung Cancer, In: (eds) , Springer, pp 91-106, 2014. In: Decision tools for radiation oncology. Prognosis, treatment response and toxicity. (Ed. Carsten N Nieder, Laurie Gaspar ) Heidelberg, Berlin: Springer, 2014, p. 91 - 106 [lung cancer].

  • Branislav Jeremic, Verna Vanderpuye, Sherif Abdel-Wahab, Papa M. Gaye,Lotfi Kochbati, Msemo Diwani, Pelagia Emwula, Bernadette Oro, Kennedy Lishimpi, Joseph Kigula-Mugambe, David Dawotola , Tigeneh Wondemagegnehu, Catherine Nyongesa, Niam Oumar, Amr El-Omrani, Tarek Shuman, Lizanne Langenhoven, Lizelle Fourie. : Patterns of practice in palliative radiotherapy in Africa – case revisited. In: Clin Oncol. 26, 2014, p. 333 - 343 [patterns of practice, palliation, radiotherapy].

  • Nenad Filipovic Tijana Djukic, Milos Radovic, Danijela Cvetkovic, Milena Curcic, Snezana Markovic, Aleksandar Peulic, Branislav Jeremic. : Electromagnetic field investigation on different cancer cell lines. In: Cancer Cell International,. 14, 2014, p. 84 [electromagnetic fields, cancer, cell lines ].

  • Branislav Jeremic.: Concurrent radiochemotherapy in Stage IIIA non-small-cell lung cancer – not just effectiveness, but very low toxicity. In: Ann Thorac Surg. 97, 2014, p. 2228 [radiotherapy, chemotherapy, stage IIIA, nonsmall cell lung cancer, toxicity].

  • Branislav Jeremic. : Concurrent hyperfraxtionated radiation therapy (Hfx RT) and low-dose, daily chemotherapy (CHT) as effective and low toxic approach in locally advanced (Stage III) nonsmall cell lung cancer (NSCLC). In: Clin Lung Cancer. 15, 2014, p. e31 - e32 [radiotherapy, low dose chemotherapy, efficacy, toxicity, stage III, nonsmall cell lung cancer].

Lang, Prof. Dr. med. Karl Sebastian

Universität Duisburg-Essen, Germany
Field of research: Hepatology
Host: Prof. Dr. Jan Buer Universität Duisburg-Essen
  • Xu HC, Grusdat M, Pandyra AA, Polz R, Huang J, Sharma P, Deenen R, Köhrer K, Rahbar R, Diefenbach A, Gibbert K, Löhning M, Höcker L, Waibler Z, Häussinger D, Mak TW, Ohashi PS, Lang KS, Lang PA: Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. In: Immunity. 40, 2014, p. 949 - 60.

  • Grusdat M, McIlwain DR, Xu HC, Pozdeev VI, Knievel J, Crome SQ, Robert-Tissot C, Dress RJ, Pandyra AA, Speiser DE, Lang E, Maney SK, Elford AR, Hamilton SR, Scheu S, Pfeffer K, Bode J, Mittrücker HW, Lohoff M, Huber M, Häussinger D, Ohashi PS, Mak TW, Lang KS, Lang PA: IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV. In: Cell Death Differ. 21, 2014, p. 1050 - 60.

  • Brenner D, Brüstle , Lin GH, Lang PA, Duncan GS, Knobbe-Thomsen CB, St Paul M, Reardon C, Tusche MW, Snow B, Hamilton SR, Pfefferle A, Gilani SO, Ohashi PS, Lang KS, Mak TW: Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. In: Proc Natl Acad Sci U S A. 111, 2014, p. 1060 - 5 [Th1/Th17 cells; inflammation].